These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31236910)

  • 21. Survival prediction models in motor neuron disease.
    Agosta F; Spinelli EG; Riva N; Fontana A; Basaia S; Canu E; Castelnovo V; Falzone Y; Carrera P; Comi G; Filippi M
    Eur J Neurol; 2019 Sep; 26(9):1143-1152. PubMed ID: 30920076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromuscular Ultrasound for Peripheral Neuropathies.
    Baute Penry V; Cartwright MS
    Semin Neurol; 2019 Oct; 39(5):542-548. PubMed ID: 31639837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis.
    Hideyama T; Momose T; Shimizu J; Tsuji S; Kwak S
    Arch Neurol; 2006 Dec; 63(12):1719-22. PubMed ID: 17172610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reappraisal of amyotrophic lateral sclerosis with dementia].
    Murakami N; Yoshida M
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1560-2. PubMed ID: 8752463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic pathways involvement in Kennedy's disease: neurophysiological and.
    Soragna D; Messa C; Mochi M; Alfonsi E; Manni R; Galimberti CA; Marchioni E
    J Neurol; 2001 Aug; 248(8):710-2. PubMed ID: 11569904
    [No Abstract]   [Full Text] [Related]  

  • 26. Scintigraphic Evaluation of Mild to Moderate Dysphagia in Motor Neuron Disease.
    Szacka K; Potulska-Chromik A; Fronczewska-Wieniawska K; Spychała A; Kròlicki L; Kuźma-Kozakiewicz M
    Clin Nucl Med; 2016 Apr; 41(4):e175-80. PubMed ID: 26914558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia-motor neuron disease patients.
    Long Z; Irish M; Piguet O; Kiernan MC; Hodges JR; Burrell JR
    J Neurol; 2019 Apr; 266(4):921-933. PubMed ID: 30707358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mills' and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET.
    Turner MR; Gerhard A; Al-Chalabi A; Shaw CE; Hughes RA; Banati RB; Brooks DJ; Leigh PN
    J Neurol Neurosurg Psychiatry; 2005 Jun; 76(6):871-4. PubMed ID: 15897516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography neuroimaging in neurodegenerative diseases: Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
    Barc K; Kuźma-Kozakiewicz M
    Neurol Neurochir Pol; 2019; 53(2):99-112. PubMed ID: 30855701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28.
    Zürcher NR; Loggia ML; Lawson R; Chonde DB; Izquierdo-Garcia D; Yasek JE; Akeju O; Catana C; Rosen BR; Cudkowicz ME; Hooker JM; Atassi N
    Neuroimage Clin; 2015; 7():409-14. PubMed ID: 25685708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease.
    Olney NT; Bischof A; Rosen H; Caverzasi E; Stern WA; Lomen-Hoerth C; Miller BL; Henry RG; Papinutto N
    PLoS One; 2018; 13(11):e0208255. PubMed ID: 30496320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal structural MRI in the diagnosis of motor neuron diseases.
    Ferraro PM; Agosta F; Riva N; Copetti M; Spinelli EG; Falzone Y; Sorarù G; Comi G; Chiò A; Filippi M
    Neuroimage Clin; 2017; 16():240-247. PubMed ID: 28794983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle ultrasonography: a diagnostic tool for amyotrophic lateral sclerosis.
    Arts IM; Overeem S; Pillen S; Kleine BU; Boekestein WA; Zwarts MJ; Jurgen Schelhaas H
    Clin Neurophysiol; 2012 Aug; 123(8):1662-7. PubMed ID: 22244867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder.
    Vázquez-Costa JF; Arlandis S; Hervas D; Martínez-Cuenca E; Cardona F; Pérez-Tur J; Broseta E; Sevilla T
    J Neurol Sci; 2017 Jul; 378():130-136. PubMed ID: 28566149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary lateral sclerosis presenting parkinsonian symptoms without nigrostriatal involvement.
    Mabuchi N; Watanabe H; Atsuta N; Hirayama M; Ito H; Fukatsu H; Kato T; Ito K; Sobue G
    J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1768-71. PubMed ID: 15548503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demographics and clinical characteristics of primary lateral sclerosis: case series and a review of literature.
    Ramanathan RS; Rana S
    Neurodegener Dis Manag; 2018 Feb; 8(1):17-23. PubMed ID: 29316850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New findings in facial-onset sensory and motor neuronopathy (FOSMN) syndrome.
    Pinto WBVR; Naylor FGM; Chieia MAT; de Souza PVS; Oliveira ASB
    Rev Neurol (Paris); 2019 Apr; 175(4):238-246. PubMed ID: 30293881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary lateral sclerosis and lung adenocarcinoma].
    Martinez L; Lamaze R; Clément-Duchêne C
    Rev Mal Respir; 2013 Mar; 30(3):227-30. PubMed ID: 23497933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Motor neuron disease: primary lateral sclerosis and amyotrophic lateral sclerosis].
    Martić V
    Vojnosanit Pregl; 2000; 57(2):205-8. PubMed ID: 10934934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary lateral sclerosis mimicking atypical parkinsonism.
    Norlinah IM; Bhatia KP; Ostergaard K; Howard R; Arabia G; Quinn NP
    Mov Disord; 2007 Oct; 22(14):2057-62. PubMed ID: 17702034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.